Heptares Therapeutics


WELWYN GARDEN CITY, England, May 9, 2011 - Heptares Therapeutics today announced it has signed an exclusive option agreement with Shire Pharmaceuticals for a novel adenosine A2A antagonist discovered by Heptares and currently in preclinical development.
Older News
S M T W T F S
24 25 26 27 28 29 30
1 2 3 4 5 6 7
8 9 10 11 12 13 14
Copyright© 2011 The Gaea Times